Search all medical codes

Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use

CPT4 code

Name of the Procedure:

Rotavirus Vaccine, Human, Attenuated (RV1), 2 Dose Schedule, Live, Oral Vaccine.

Summary

The Rotavirus vaccine (RV1) is a live, attenuated vaccine administered orally in two doses to protect infants and young children against rotavirus, a virus that causes severe diarrhea and vomiting.

Purpose

The vaccine aims to provide immunity against rotavirus, significantly reducing the likelihood of severe gastroenteritis, which can lead to dehydration and hospitalization in young children.

Indications

  • Infants aged 6 weeks to 24 weeks.
  • Recommended as part of routine childhood immunizations.
  • Particularly indicated for children attending daycare or living in settings with high infection risk.

Preparation

  • No specific preparation required.
  • Ensure the child is healthy and free of severe acute illness at the time of vaccination.
  • No contraindications like severe allergic reactions to vaccine components.

Procedure Description

  1. Preparation: Healthcare provider explains the procedure to the parent or guardian.
  2. Administration: The child is positioned comfortably.
  3. Oral Delivery: The vaccine is administered orally using a pre-filled applicator.
  4. Observation: The child is observed for a short period for any immediate reactions.

No needles are involved, and anesthesia or sedation is not required.

Duration

The procedure takes only a few minutes.

Setting

Performed at pediatrician offices, outpatient clinics, or community health centers.

Personnel

Administered by healthcare professionals, typically a nurse or pediatrician.

Risks and Complications

  • Common: Mild fussiness, diarrhea, or vomiting.
  • Rare: Intussusception (a type of bowel blockage), allergic reactions.

Benefits

  • Highly effective in preventing severe rotavirus infections.
  • Reduction in medical visits, hospitalizations, and associated medical costs.
  • Provides immunity typically within 2 weeks after the second dose.

Recovery

  • Post-vaccination care is minimal; usual activities can be resumed immediately.
  • Monitor for any signs of adverse reactions and follow up if necessary.

Alternatives

  • Other rotavirus vaccines (e.g., RV5) with a three-dose schedule.
  • Benefits: Alternative schedules might suit some medical conditions.
  • Conclusion: RV1 is a reliable and effective option for most infants.

Patient Experience

  • Typically well-tolerated with minimal discomfort.
  • Parents should be aware of and monitor for mild side effects like diarrhea or fussiness.
  • Any pain or discomfort is usually short-lived and manageable.

Medical Policies and Guidelines for Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use

Related policies from health plans

Similar Codes